1. Home
  2. Press release
Sep 17, 2020 09:59 JST

Source: Eisai

Eisai Establishes Pharma Sales Subsidiary in Vietnam


TOKYO, Sep 17, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has established a new pharmaceutical sales subsidiary in Ho Chi Minh City, the Socialist Republic of Viet Nam (Vietnam), which will be named Eisai Vietnam Co., Ltd. (Eisai Vietnam). Eisai Vietnam is a wholly-owned subsidiary of Eisai.

The pharmaceutical market in Vietnam is surpassed in size only by those of Thailand and the Philippines within the Association of Southeast Asian Nations (ASEAN), with the market size reaching 4,199 million USD in 20191. The compound annual growth rate of the Vietnamese pharmaceutical market from 2014 to 2019 was +10.6%(1), and it is expected that this market rate will continue to grow in the double digits. In 1992, Eisai (Thailand) Marketing Co., Ltd., a pharmaceutical sales subsidiary of Eisai, started business in Vietnam through a local agency. Eisai opened a representative office in Ho Chi Minh City in 1995, and mainly markets the proton-pump inhibitor Pariet, muscle relaxant Myonal, peripheral neuropathy treatment Methycobal, and others.

In addition, regarding its global products in Vietnam, Eisai recently launched its antiepileptic drug Fycompa in October 2019, and obtained marketing approval for the anti-cancer agent Lenvima in June 2020. Eisai has also filed for regulatory approval for the in-house developed anti-cancer agent Halaven.

With the establishment of Eisai Vietnam, Eisai aims to enhance its own drug sales system in Vietnam, deliver innovative new drugs to more patients in Vietnam, and contribute to improving the benefits of patients and their families.

(1) Copyright 2020 IQVIA Created based on IQVIA Analytics Link 2014-2019. Unauthorized reproduction prohibited.

Contact:
Media Inquiries:
Public Relations Department
Eisai Co., Ltd. 
+81-(0)3-3817-5120
Source: Eisai
Sectors: BioTech

Copyright ©2021 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release

Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium
January 12 2021 11:37 JST
 
Eisai Completes Construction of the 5th Manufacturing Building at Kawashima Industrial Park in Japan
December 18 2020 12:09 JST
 
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Demonstrated Statistically Significant Improvement in OS, PFS and ORR
December 17 2020 11:47 JST
 
Eisai: Biogen Files New Drug Application for Aducanumab in Japan
December 11 2020 09:43 JST
 
Eisai to Present Abstracts on Oncology Products and Pipeline at 43rd Annual San Antonio Breast Cancer Symposium
December 04 2020 11:17 JST
 
Eisai to Present Latest Data on Perampanel at the 74th American Epilepsy Society Annual Meeting
November 30 2020 13:04 JST
 
Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies
November 30 2020 10:16 JST
 
AbbVie and Eisai Announce an approval for additional indication of HUMIRA
November 27 2020 21:05 JST
 
Eisai Selected for Membership in Dow Jones Sustainability Asia Pacific Index 2020 for Seventh Time
November 18 2020 19:11 JST
 
Eisai: Jyseleca (Filgotinib) for Rheumatoid Arthritis Launches in Japan
November 18 2020 19:00 JST
 
More Press release >>

Latest Press Release


Shell, Mitsubishi Heavy Industries, Vattenfall and Warme Hamburg sign Letter of Intent for 100MW Hydrogen Project in Hamburg
Jan 22, 2021 22:23 JST

Low Carbon on Cement Possible with CCS
Jan 22, 2021 09:04 JST

MHIET Conducts Combustion Test for Hydrogen Engine with Pure Hydrogen
Jan 21, 2021 17:38 JST

Fujitsu Delivers Cashless, Contactless Retail Experience for Masked Shoppers with Hygienic, Multi-Factor Biometric Authentication Technology
Jan 21, 2021 10:05 JST

Honda, Cruise and GM Take Next Steps Toward Autonomous Vehicle Mobility Service Business in Japan
Jan 20, 2021 11:29 JST

DENSO Collaborates with Aeva to Bring New LiDAR to Market
Jan 20, 2021 09:34 JST

Mitsubishi Corporation: Commercial Operations Commence at Methanol / Dimethyl Ether Plant in Trinidad and Tobago
Jan 19, 2021 10:25 JST

TOYOTA GAZOO Racing Targets the Top Step on Classic Season Opener
Jan 18, 2021 18:08 JST

Second Overall as Toyota Gazoo Racing Fights To the End of Dakar 2021
Jan 18, 2021 17:30 JST

SDK to increase capacity of aluminum substrate for hard disks
Jan 15, 2021 10:00 JST

Toyota Gazoo Racing Introduces GR010 Hybrid Hypercar
Jan 15, 2021 08:37 JST

New-Look Toyota Yaris Wrc Ready to Fight for More Titles in 2021
Jan 15, 2021 08:16 JST

NEC Concludes Contract to Supply the Palau Cable 2 (PC2) Optical Submarine Cable
Jan 14, 2021 14:01 JST

Fujitsu Leverages Deep Learning to Achieve World's Most Accurate Recognition of Complex Actions and Behaviors Based on Skeleton Data
Jan 13, 2021 10:55 JST

Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium
Jan 12, 2021 12:37 JST

Thailand's First Demonstration Project of Optimized Performance Enabling Network for Volt/Var(Q) (OPENVQ) in Power Transmission Networks
Jan 12, 2021 12:21 JST

NEC Releases 'WISE VISION Endoscopy' in Europe and Japan
Jan 12, 2021 10:56 JST

Norwegian Block Exchange (NBX) Raises Capital for Growth
Jan 12, 2021 07:30 JST

MHI Thermal Systems Receives 2020 "Agency for Natural Resources and Energy Commissioner's Award" for MSV2 Series of High-efficiency, Air-cooled Heat Pump Chillers
Jan 07, 2021 15:20 JST

Olympus and Hitachi Announce Long-Term Business Alliance regarding Endoscopic Ultrasound Systems
Jan 06, 2021 18:48 JST
 More Latest Release >>